We collected information about Durect Corporation Hours for you. Follow the liks to find out everything about Durect Corporation Hours.
https://www.linkedin.com/jobs/view/sr-customer-service-representative-part-time-at-durect-corporation-2819514276#:~:text=This%20is%20a%20part-time%20%2820%20hours%2Fweek%29%20position.%20DURECT,located%20in%20Cupertino%2C%20CA.%20Main%20Duties%20%26%20Responsibilities
DURECT Corporation Doses First ex-U.S. Patient in Phase 2b AHFIRM Study of Larsucosterol (DUR-928) in Severe Alcohol-Associated Hepatitis. November 10, 2021. DURECT Corporation Announces Poster Presentation on the Prevalence of Hospitalized Alcohol-Associated Hepatitis (AH) Patients in the U.S. to be Presented at The Liver Meeting® 2021.
https://www.nasdaq.com/market-activity/stocks/drrx/after-hours
After-Hours Trades. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as...
https://www.durect.com/contact
DURECT Corporation 10260 Bubb Road Cupertino, CA 95014-4166 Phone: 408-346-1052 Email: [email protected]. Product Inquiries. ALZET ...
https://investors.durect.com/
Overview. DURECT is committed to transforming the treatment of acute organ injury and chronic liver diseases by advancing novel and lifesaving therapies based on its endogenous epigenetic regulator program. The company’s lead candidate, larsucosterol (DUR-928), is the first endogenous epigenetic regulator clinically tested for difficult-to ...
https://investors.durect.com/news-releases/news-release-details/durect-corporation-announces-us-fda-approval-posimirr-post
To report SUSPECTED ADVERSE REACTIONS, contact DURECT Corporation at 1-844-767-4647 or FDA at 1–800–FDA-1088 or www.fda.gov/medwatch. Conference Call. The DURECT management team will host a conference call to discuss the contents of this press release today at 4:30pm ET / 1:30pm PT: Toll Free: 877-407-0784 International: 201-689-8560
https://finance.yahoo.com/quote/DRRX
DURECT Corporation to Announce Third Quarter 2021 Financial Results and Provide Business Update on November 2. DURECT Corporation (Nasdaq: DRRX) today announced that it …
https://www.investors.durect.com/news-releases
https://finance.yahoo.com/news/durect-corporation-announces-u-fda-130100595.html
DURECT Corporation (Nasdaq: DRRX) today announced that the U.S. Food and Drug Administration (FDA) has approved POSIMIR® (bupivacaine solution) for infiltration use in adults for administration ...
https://www.nasdaq.com/market-activity/stocks/drrx/after-hours-trades
4:00 - 4:29. 4:30 - 4:59. 5:00 - 5:29. 5:30 - 5:59. 6:00 - 6:29. 6:30 - 6:59. 7:00 - 7:29. 7:30 - 7:59. After Hours Time (ET)
POSIMIR is a bupivacaine solution indicated in adults for administration into the subacromial space under direct arthroscopic visualization to produce post-surgical analgesia for up to 72 hours following arthroscopic subacromial decompression. Safety and effectiveness have not been established in other surgical procedures, including soft tissue ...
Searching for Durect Corporation Hours?
You can just click the links above. The info is collected for you.
